IL78197A - Nucleic acid encoding tgf-beta and its uses - Google Patents

Nucleic acid encoding tgf-beta and its uses

Info

Publication number
IL78197A
IL78197A IL78197A IL7819786A IL78197A IL 78197 A IL78197 A IL 78197A IL 78197 A IL78197 A IL 78197A IL 7819786 A IL7819786 A IL 7819786A IL 78197 A IL78197 A IL 78197A
Authority
IL
Israel
Prior art keywords
beta
nucleic acid
acid encoding
encoding tgf
tgf
Prior art date
Application number
IL78197A
Other languages
English (en)
Other versions
IL78197A0 (en
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL78197A0 publication Critical patent/IL78197A0/xx
Publication of IL78197A publication Critical patent/IL78197A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL78197A 1985-03-22 1986-03-19 Nucleic acid encoding tgf-beta and its uses IL78197A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71514285A 1985-03-22 1985-03-22

Publications (2)

Publication Number Publication Date
IL78197A0 IL78197A0 (en) 1986-07-31
IL78197A true IL78197A (en) 1991-07-18

Family

ID=24872822

Family Applications (1)

Application Number Title Priority Date Filing Date
IL78197A IL78197A (en) 1985-03-22 1986-03-19 Nucleic acid encoding tgf-beta and its uses

Country Status (7)

Country Link
EP (1) EP0200341B1 (xx)
JP (2) JPH0659230B2 (xx)
AT (1) ATE99737T1 (xx)
DE (1) DE3689495T2 (xx)
DK (1) DK175412B1 (xx)
IE (1) IE61119B1 (xx)
IL (1) IL78197A (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012101A1 (en) * 1988-06-08 1989-12-14 Genentech, Inc. NUCLEIC ACID ENCODING TGF-beta3 AND ITS USE
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
AU1340688A (en) * 1987-01-30 1988-08-24 Techne Corporation Transforming growth factor-beta
US4931548A (en) * 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
JPS6463395A (en) * 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
EP0293785A3 (en) 1987-05-29 1990-05-02 Oncogen Limited Partnership Cloning and expression of simian transforming growth factor-ss1
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
IL87877A0 (en) * 1987-10-06 1989-03-31 Oncogen Cloning and expression of transforming growth factor beta2
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
CA2070393A1 (en) * 1989-10-18 1991-04-19 Charles M. Cohen Biosynthetic constructs of tgf-beta
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
TW517059B (en) 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
ES2213221T3 (es) * 1996-07-29 2004-08-16 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Und Zum Vertrieb Von Pharmaka Mbh Factor de tipo egf de granulos de cromafina y factor neurotrofico derivado de celulas de glia con actividad promotora de la supervivencia sobre neuronas daergicas.
GB9822682D0 (en) * 1998-10-16 1998-12-09 Gemini Research Limited Diagnostic method and apparatus based on polymorphism in a TGF-B-Gene
WO2000054797A2 (en) 1999-03-17 2000-09-21 Novartis Ag Pharmaceutical compositions comprising tgf-beta
US7211271B2 (en) 2001-03-12 2007-05-01 The Regents Of The University Of California Method to improve hydroxyapatite implantation and stimulate bone regeneration
NZ550217A (en) 2004-03-31 2009-11-27 Genentech Inc Humanized anti-TGF-beta antibodies
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
SG176476A1 (en) 2006-11-02 2011-12-29 Daniel J Capon Hybrid immunoglobulins with moving parts
JP7125933B2 (ja) * 2017-05-02 2022-08-25 株式会社カネカ 免疫グロブリン結合活性を有するポリペプチドの回収精製法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154434B1 (en) * 1984-02-17 1993-01-27 Genentech, Inc. Human transforming growth factor and precursor or fragment thereof, cells, dna, vectors and methods for their production, compositions and products containing them, and related antibodies and diagnostic methods

Also Published As

Publication number Publication date
DK175412B1 (da) 2004-09-27
IE61119B1 (en) 1994-10-05
ATE99737T1 (de) 1994-01-15
DK127786A (da) 1986-09-23
DE3689495D1 (de) 1994-02-17
JPH0659230B2 (ja) 1994-08-10
EP0200341A1 (en) 1986-11-05
EP0200341B1 (en) 1994-01-05
IE860743L (en) 1986-09-22
DK127786D0 (da) 1986-03-20
DE3689495T2 (de) 1994-06-01
JPH06169777A (ja) 1994-06-21
JPS61219395A (ja) 1986-09-29
JPH0763378B2 (ja) 1995-07-12
IL78197A0 (en) 1986-07-31

Similar Documents

Publication Publication Date Title
IL78197A0 (en) Nucleic acid encoding tgf-beta and its uses
EP0244234A3 (en) Transformation of trichoderma
SG46627A1 (en) Recombinant expression vectors and purification methods for thermus thermophilus dna polymerase
IL74909A (en) Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
DE3279788D1 (en) Human immune interferon
AU6733487A (en) Mammalian interleukin-4
EP0251037A3 (en) Novel human tnf polypeptide mutants and dnas encoding said mutants
DK139493A (da) Rekombinant plasmid, bakteriekultur transformeret dermed samt kulturens anvendelse
DE3688671D1 (de) Menschliches interferon-beta2a vektoren, die gene enthalten, die fuer das genannte interferon kodieren zellinien, die dieses produzieren und verwendung des genannten interferons als pharmazeutikum.
ES8305420A1 (es) Un procedimiento de sintesis de proinsulina humana
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
GB2191491B (en) Dna segment coding for a specific lipase, vectors for the expression thereof, microorganisms transformed by these vectors and use of these microorganisms for
EP0139076A3 (en) Human-parathyroid hormone (human-pth) producing hybrid vectors, human-parathyroid hormone gene, eucaryotic cells containing the hybrid vector and their use
GB8628113D0 (en) Dna & strains of bacillus subtilis
AU1321988A (en) The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
DE69119461T2 (de) Strukturgen von membrangebundenem Alkoholdehydrogenase-Komplex, Plasmid, das dieses Gen enthält und transformierte Essigsäurebakterien
ATE63135T1 (de) Transformationsvektoren fuer mikroorganismen mit guenstiger rhizospherischer wirkung, transformierte staemme und landwirtschaftliche verwendung.
LV5677A3 (lv) Bakteriju lactobacillus casei var. alactosus celms - L(+)-pienskabes producents izmantojams lopbaribas konservesanai
IT8719124A0 (it) Procedimento per l'introduzione di dna plasmidiale in ceppi batterici del genere lactobacillus e costruzione di vettori plasmidiali specifici.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed